PREMIER CALIBRATIONS LTD
Company number 03406723 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: Premier Calibrations Ltd
Financial Health Score: B+
Explanation: The company has demonstrated an extraordinary recovery from a near-critical condition in 2020 (negative net assets of £-12,402) to a robust financial position in 2025 (net assets of £303,971). This represents a remarkable turnaround that speaks to strong operational management. The score is held back from an A grade by some lingering structural concerns—specifically, the significant and growing provisions, and the concentration of liabilities in "other creditors" that warrant closer monitoring. The trajectory, however, is overwhelmingly positive.
Key Vital Signs
1. Net Assets (The Company's "Body Mass Index")
| Year | Net Assets | Year-on-Year Change |
|---|---|---|
| 2020 | £-12,402 | — |
| 2021 | £63,954 | +£76,356 |
| 2022 | £177,671 | +£113,717 |
| 2023 | £187,118 | +£9,447 |
| 2024 | £196,609 | +£9,491 |
| 2025 | £303,971 | +£107,362 |
Interpretation: This is the financial equivalent of a patient who was critically underweight and has not only recovered but built significant muscle mass. The journey from negative net assets to over £300k represents a total transformation of approximately £316,000 in five years. The most recent year shows the largest single-year gain, indicating accelerating financial strength.
2. Cash Position (The "Blood Pressure")
| Year | Cash | Cash as % of Current Assets |
|---|---|---|
| 2019 | £496 | 0.6% |
| 2020 | £37,142 | 57.4% |
| 2021 | £78,878 | 52.2% |
| 2022 | £110,390 | 60.3% |
| 2023 | £135,339 | 51.9% |
| 2024 | £75,126 | 32.9% |
| 2025 | £108,343 | 39.1% |
Interpretation: The 2019 cash position of just £496 was dangerously low—the financial equivalent of critically low blood pressure where the patient is at risk of "financial cardiac arrest." The recovery to £108,343 is excellent, though the dip in 2024 and the percentage decline from the 2022 peak suggest cash is being actively deployed into the business (as evidenced by significant capital expenditure). Current cash levels are healthy and adequate for operational needs.
3. Liquidity Ratio (The "Circulatory Health")
Current Ratio (2025): £277,128 ÷ £169,853 = 1.63:1
Quick Ratio (2025): (£277,128 - £2,700) ÷ £169,853 = 1.62:1
Interpretation: A current ratio of 1.63:1 is in the healthy range—like good circulation. The company can comfortably meet its short-term obligations. The near-identical quick ratio confirms this isn't dependent on selling stock (which is minimal at £2,700), indicating genuine liquid strength.
4. Gearing/Leverage (The "Cholesterol Level")
Total Liabilities to Net Assets: £169,853 ÷ £303,971 = 0.56:1 (or 56%)
Interpretation: This is a moderate and manageable level—like having acceptable cholesterol. The company is not over-leveraged, but neither is it debt-free. The composition of these liabilities deserves attention (see Diagnosis section).
5. Profitability Indicator (The "Metabolic Rate")
Estimated Retained Profit (2025): £303,871 - £196,509 = £107,362
This is derived from the movement in profit and loss reserves, representing the profit retained in the business after any dividends.
Interpretation: A strong and accelerating metabolic rate. The business is generating substantial profits and retaining them for growth. The 2025 figure represents approximately a 55% increase over the 2024 retained profit, indicating excellent earnings momentum.
Diagnosis
What the Financial Data Reveals About Business Health
Overall Condition: The patient has made a remarkable recovery and is now in good health, though some underlying conditions require monitoring.
Positive Findings (Signs of Robust Health)
-
Dramatic Turnaround Completed: The journey from negative net assets in 2020 to £304k in 2025 demonstrates exceptional business resilience and management capability. This is the financial equivalent of a patient recovering from a life-threatening illness and going on to run marathons.
-
Strong Capital Investment: The addition of £175,295 in tangible fixed assets during 2025 (growing from £287,824 to £397,094 in net book value) shows management is investing confidently in the future. This is a business that is building capacity, not milking existing assets.
-
Growing Workforce: Employee numbers increased from 5 to 7, representing 40% headcount growth. This signals both confidence in future demand and investment in service delivery capability.
-
Healthy Cash Generation: Despite significant capital investment, the company has maintained over £100k in cash—demonstrating that operations are generating sufficient cashflow to fund growth and maintain a buffer.
-
Going Concern Confirmed: The directors have explicitly confirmed they expect the company to continue in operational existence for the foreseeable future, adopting the going concern basis.
-
Clean Filing Record: Accounts are filed on time and not overdue, indicating good financial governance and administrative health.
Areas of Concern (Symptoms Requiring Monitoring)
- Significant and Growing Provisions: £99,273 (up from £74,902)
This is the financial equivalent of a chronic condition that needs management. Provisions represent anticipated future liabilities, and a 32% year-on-year increase is notable. At nearly £100k, these provisions represent approximately one-third of net assets. Without knowing the nature of these provisions, they represent a material uncertainty. They could relate to: - Deferred tax liabilities (likely given the asset growth) - Legal or contractual obligations - Warranty or guarantee commitments
Risk Level: Moderate—needs investigation but not immediately threatening.
- Concentration in "Other Creditors"
| Category | 2025 | 2024 |
|---|---|---|
| Other creditors (current) | £107,024 | £104,445 |
| Other creditors (non-current) | £80,162 | £58,442 |
| Total other creditors | £187,186 | £162,887 |
These "other creditors" represent the largest single category of liabilities and have increased by £24,299 (15%). This could include director loans, related party balances, or HP/lease obligations for the significant asset additions. The opacity of this category is a diagnostic challenge—like a symptom that could be benign or concerning depending on the underlying cause.
- Trade Debtors Growth: £150,382 (up from £142,742)
A 5.4% increase in trade debtors isn't alarming in isolation, but combined with the 40% increase in employee count and significant capital investment, it's worth monitoring whether this represents genuine growth or slower collection. The debtor days calculation would require turnover data (which small companies aren't required to file), so this remains a diagnostic question mark.
- Long-term Liability Growth
Non-current liabilities increased from £84,542 to £101,125 (a 19.6% increase), driven primarily by the increase in other creditors from £58,442 to £80,162. This suggests the asset expansion has been partly funded by longer-term obligations. While not immediately concerning given the strong net asset position, this trend bears watching.
- Limited Financial Transparency
As a small company filing under the "Total Exemption Full" regime, Premier Calibrations Ltd does not file a profit and loss account. This means key metrics like turnover, gross margin, and operating profit are not publicly visible. For a thorough health check, these would be essential diagnostics.
Prognosis
Future Financial Outlook: Positive with Monitoring Required
The financial trajectory is strongly positive. The company has demonstrated:
- Resilience: Survived and thrived through the challenging 2020 period
- Growth capacity: Significant investment in fixed assets and people
- Profitability: Consistent and growing retained profits
- Cash generation: Ability to fund investment while maintaining cash reserves
The primary risks to this positive outlook are:
- The nature and resolution of the £99k in provisions
- The terms and conditions attached to the £187k in "other creditors"
- The sustainability of the current growth trajectory given the increased fixed cost base
If the provisions relate to deferred tax (which is probable given the revaluation of properties mentioned in the accounting policies), this is manageable. If they relate to litigation or contractual disputes, the risk profile changes significantly.
Recommendations
Specific Actions to Improve Financial Wellness
Immediate Actions (The "Prescription")
-
Investigate and Document Provisions: Request clarity on the £99,273 in provisions. If these are primarily deferred tax arising from property revaluations, this can be documented and monitored. If they represent other obligations, a plan for resolution should be established. This is the most important diagnostic step.
-
Review "Other Creditors" Composition: Understand what comprises the £187,186 in total other creditors. If a significant portion represents director loans, this is actually positive (flexible, patient capital). If it represents HP or lease obligations for the new equipment, ensure the repayment terms are sustainable against cashflow.
-
Debtor Management: With trade debtors at £150,382 and growing, implement or review credit control procedures. Consider whether the 5.4% growth in debtors is proportionate to revenue growth.
Medium-Term Health Maintenance (The "Wellness Programme")
-
Cashflow Forecasting: Given the significant capital investment (£175k in additions), develop rolling 12-month cashflow forecasts to ensure the business can meet all obligations as they fall due, particularly if the growth trajectory continues.
-
Monitor the Current Ratio Trend: The current ratio has improved significantly from 2020, but track this quarterly. A ratio below 1.5:1 in future periods would warrant attention, particularly given the growing non-current liabilities.
-
Review Asset Utilisation: With £397,094 in net tangible assets and 7 employees, ensure the expanded asset base is generating adequate returns. The estimated £107k profit on approximately £400k in assets represents a return on assets of approximately 27%—which is excellent, but should be monitored as the asset base grows.
-
Consider Dividend Policy: With £303,871 in retained profits and only £100 in share capital, the company has significant distributable reserves. While retaining profits for growth is sensible, the shareholder-directors may wish to consider a modest dividend to reward the patience shown during the 2020 recovery period—provided this doesn't compromise the cash position.
Long-Term Strategic Health (The "Lifestyle Changes")
-
Succession Planning: The PSC register shows two individuals (name shown to subscribers and name shown to subscribers) each owning 25-50% of the company. As a business that has been operating since 1997 (28 years), ensure there is a clear succession plan and that the business is not overly dependent on key individuals.
-
Voluntary Enhanced Disclosure: While not required for small companies, consider voluntarily filing a profit and loss account. This would improve transparency for any future credit applications, potential investors, or business sale scenarios.
-
Build Cash Reserves for Cyclical Downturns: The company has demonstrated vulnerability to economic shocks (as shown in the 2020 position). With the business now generating strong profits, aim to build cash reserves equivalent to at least 3 months of operating costs as a buffer against future disruptions.
Summary Dashboard
| Vital Sign | Status | Trend |
|---|---|---|
| Net Assets | ✅ Healthy | ↑ Strongly improving |
| Cash Position | ✅ Adequate | ↑ Recovering after dip |
| Liquidity | ✅ Good (1.63:1) | → Stable |
| Gearing | ⚠️ Moderate (56%) | → Manageable |
| Profitability | ✅ Strong | ↑ Accelerating |
| Provisions | ⚠️ Needs investigation | ↑ Growing |
| Filing Compliance | ✅ Current | ✅ On time |
Overall Verdict: A business that has recovered from a near-fatal financial condition and is now in robust health. The primary areas of uncertainty—the provisions and other creditors—require diagnostic investigation but are unlikely to represent terminal conditions. The investment in assets and people signals management confidence in the future. With continued prudent management, the prognosis is excellent.